PL2448590T3 - Medyczne węglowodany do leczenia stanów układu oddechowego - Google Patents

Medyczne węglowodany do leczenia stanów układu oddechowego

Info

Publication number
PL2448590T3
PL2448590T3 PL10793441T PL10793441T PL2448590T3 PL 2448590 T3 PL2448590 T3 PL 2448590T3 PL 10793441 T PL10793441 T PL 10793441T PL 10793441 T PL10793441 T PL 10793441T PL 2448590 T3 PL2448590 T3 PL 2448590T3
Authority
PL
Poland
Prior art keywords
carbohydrates
medicinal
treatment
respiratory conditions
respiratory
Prior art date
Application number
PL10793441T
Other languages
English (en)
Inventor
Betty Jin
Paul Arthur Jones
Ee Ling Seah
Wen Yang Wu
Peter James Jenkins
Original Assignee
Australian Biomedical Company Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009903123A external-priority patent/AU2009903123A0/en
Application filed by Australian Biomedical Company Pty Ltd filed Critical Australian Biomedical Company Pty Ltd
Publication of PL2448590T3 publication Critical patent/PL2448590T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10793441T 2009-07-03 2010-07-02 Medyczne węglowodany do leczenia stanów układu oddechowego PL2448590T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009903123A AU2009903123A0 (en) 2009-07-03 Carbohydrates
PCT/AU2010/000846 WO2011000053A1 (en) 2009-07-03 2010-07-02 Medicinal carbohydrates for treatment of respiratory conditions
EP10793441.6A EP2448590B1 (en) 2009-07-03 2010-07-02 Medicinal carbohydrates for treatment of respiratory conditions

Publications (1)

Publication Number Publication Date
PL2448590T3 true PL2448590T3 (pl) 2019-05-31

Family

ID=43410378

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10793441T PL2448590T3 (pl) 2009-07-03 2010-07-02 Medyczne węglowodany do leczenia stanów układu oddechowego

Country Status (19)

Country Link
US (2) US9040503B2 (pl)
EP (1) EP2448590B1 (pl)
JP (2) JP6057709B2 (pl)
KR (1) KR101843391B1 (pl)
CN (2) CN107126436B (pl)
AU (1) AU2010268689B2 (pl)
BR (1) BR112012000101B8 (pl)
CA (1) CA2766239C (pl)
DK (1) DK2448590T3 (pl)
ES (1) ES2709680T3 (pl)
IL (1) IL217185A (pl)
NZ (1) NZ597044A (pl)
PL (1) PL2448590T3 (pl)
PT (1) PT2448590T (pl)
RU (1) RU2539899C2 (pl)
SG (1) SG176732A1 (pl)
UA (1) UA110325C2 (pl)
WO (1) WO2011000053A1 (pl)
ZA (1) ZA201109040B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
WO2014151523A1 (en) * 2013-03-15 2014-09-25 Huiru Wang Compositions and products for infectious or inflammatory diseases or conditions
CN113101294A (zh) 2013-03-15 2021-07-13 杭州惠瑞生物医药有限公司 感染相关疾病或病症的生物治疗产品
US10493087B2 (en) 2015-02-25 2019-12-03 The United States of America, as represented by National Institute of Health Sialylation-increasing therapies for diseases associated with oxidative stress
CN109288114A (zh) * 2018-10-08 2019-02-01 厦门艾赛生物科技有限公司 一种唾液酸及其衍生物的应用和唾液酸电子烟液
EP4329771A4 (en) * 2021-05-31 2024-07-24 B & H Biotechnologies, LLC APPLICATIONS OF SIALIC ACID ANALOGUES OR DERIVATIVES

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6168418A (ja) * 1984-09-11 1986-04-08 Kanto Ishi Pharma Co Ltd 去痰薬
US5874261A (en) 1988-09-02 1999-02-23 The Trustees Of The University Of Pennsylvania Method for the purification of glycosyltransferases
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent
JPH02177891A (ja) 1988-12-28 1990-07-10 Snow Brand Milk Prod Co Ltd 複合酵素反応によるシチジン‐５′‐モノホスフオシアル酸の合成方法
JPH03206050A (ja) * 1989-12-29 1991-09-09 Mitsui Toatsu Chem Inc 医薬組成物
JP3206050B2 (ja) 1991-11-18 2001-09-04 住友電気工業株式会社 ダイヤモンド単結晶の合成方法
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
US5834423A (en) 1994-07-15 1998-11-10 Taiyo Kagaku Co., Ltd. Pharmaceutical composition containing sialic acid derivatives
JPH08337532A (ja) * 1995-06-14 1996-12-24 Takeda Chem Ind Ltd 医薬組成物
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
JP2000503630A (ja) * 1995-11-22 2000-03-28 ザ リサーチ アンド ディベロップメント インスティチュート，インコーポレイテッド 微生物感染症の治療用治療剤及び診断剤
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
EP0837511B1 (en) 1996-10-15 2005-09-14 Matsushita Electric Industrial Co., Ltd Solar cell and method for manufacturing the same
CN1067245C (zh) 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗呼吸道疾病的药物中的应用
JPH11206050A (ja) * 1998-01-16 1999-07-30 Mitsubishi Heavy Ind Ltd 磁石モータ
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
JP2001131074A (ja) 1999-08-20 2001-05-15 Inst Of Physical & Chemical Res シアル酸誘導体を有効成分として含む医薬
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
JP2002265365A (ja) * 2001-03-08 2002-09-18 Koyo Chemical Kk 好中球機能抑制剤
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
AU2002314881A1 (en) * 2001-06-07 2002-12-23 Rigel Pharmaceuticals, Inc. Cd43:modulators of mast cell degranulation
US20070259094A1 (en) * 2002-10-21 2007-11-08 Willem Wassenaar N-acetylglucosamine as a food and beverage additive
TWI269656B (en) * 2003-03-05 2007-01-01 Original Image Co Ltd Therapeutical composition for hepatitis C
CN1533776A (zh) * 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用
US20060193824A1 (en) 2005-02-28 2006-08-31 Rubin Bruce K Methods for the treatment of infectious and inflammatory airway diseases
US9315532B2 (en) * 2005-05-24 2016-04-19 The Johns Hopkins University Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods thereof
JP2008273919A (ja) * 2007-05-07 2008-11-13 Lilac:Kk 組織・細胞障害のための予防・修復剤
WO2008150477A2 (en) * 2007-05-31 2008-12-11 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine as a therapeutic agent
WO2009020641A1 (en) * 2007-08-08 2009-02-12 The Johns Hopkins University Hybrid scfa-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions

Also Published As

Publication number Publication date
KR101843391B1 (ko) 2018-03-29
EP2448590B1 (en) 2018-10-31
AU2010268689B2 (en) 2013-07-18
IL217185A0 (en) 2012-02-29
US9040503B2 (en) 2015-05-26
CA2766239C (en) 2017-08-22
EP2448590A1 (en) 2012-05-09
BR112012000101B1 (pt) 2021-02-23
BR112012000101A2 (pt) 2016-04-05
SG176732A1 (en) 2012-01-30
JP6057709B2 (ja) 2017-01-11
US20120142619A1 (en) 2012-06-07
NZ597044A (en) 2013-08-30
US20150238512A1 (en) 2015-08-27
RU2011150894A (ru) 2013-08-10
CN107126436A (zh) 2017-09-05
KR20120050441A (ko) 2012-05-18
BR112012000101B8 (pt) 2021-05-25
UA110325C2 (en) 2015-12-25
DK2448590T3 (en) 2019-02-25
CN102665728A (zh) 2012-09-12
EP2448590A4 (en) 2013-05-15
IL217185A (en) 2015-03-31
WO2011000053A1 (en) 2011-01-06
US10195226B2 (en) 2019-02-05
ES2709680T3 (es) 2019-04-17
JP2016026170A (ja) 2016-02-12
CN107126436B (zh) 2020-06-02
PT2448590T (pt) 2018-12-06
CA2766239A1 (en) 2011-01-06
ZA201109040B (en) 2013-02-27
AU2010268689A1 (en) 2012-01-12
RU2539899C2 (ru) 2015-01-27
JP2012531445A (ja) 2012-12-10

Similar Documents

Publication Publication Date Title
IL219073A (en) A drug combination for cancer treatment
IL259475A (en) Combined therapy for the treatment of diabetes
EP2448622A4 (en) NEBULIZER FOR INFANTS AND PATIENTS WITH RESPIRATORY PROBLEMS
ZA201205829B (en) Treatment of respiratory disorders
AU339607S (en) Medical device for treatment of sleep disorders
IL217777A0 (en) Methods for treatment of pain
GB0915515D0 (en) Treatment of vasculoproliferative conditions
GB0908193D0 (en) Treatment of disease state
ZA201208646B (en) Pharmaceutical combination for the treatment of pain
GB0902040D0 (en) Composition for treatment of skin
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
IL206491A0 (en) Treatment of produce
EP2638389A4 (en) TREATMENT OF EXTRACTION OF RENEWAL
IL217185A0 (en) Medicinal carbohydrates for treatment of respiratory conditions
GB201002224D0 (en) Respiratory disease treatment
IL215695A (en) Use of Compounds 1-Phenyl-3-Dimethyl Amino Propane for the preparation of rheumatic pain medication
ZA201207696B (en) Compound for treatment of respiratory condition or disease
IL215854A0 (en) Pharmaceutical compositions for the treatment of nasal polyposis
TWM390783U (en) Improved structure of push bed for medical treatment
GB201001912D0 (en) Treatment of respiratory disorders
GB0901831D0 (en) Respiratory disease treatment
GB0901832D0 (en) Respiratory disease treatment
GB0910944D0 (en) Respiratory disease treatment
GB0908666D0 (en) Treatment of proteostatic disease
GB0913427D0 (en) Compounds for treatment of imflammation